Zealand Pharma A/S (ZEAL) and trades at $17.59. The 52-week range is 9.93-32.12.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.7, Earnings Per Share (EPS) of $-26.54, annual revenue of $292.57M.
The stock has a beta of 1.34, operates in the Healthcare sector.
